{"id":779,"date":"2020-11-19T23:43:47","date_gmt":"2020-11-20T03:43:47","guid":{"rendered":"https:\/\/minutocerord.com\/?p=779"},"modified":"2020-11-19T23:43:50","modified_gmt":"2020-11-20T03:43:50","slug":"estados-unidos-aprobo-el-uso-de-emergencia-del-medicamento-baricitinib-para-tratamientos-contra-el-covid-19","status":"publish","type":"post","link":"https:\/\/minutocerord.com\/?p=779","title":{"rendered":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19"},"content":{"rendered":"\n<p>Las autoridades sanitarias de Estados Unidos aprobaron este jueves el uso de emergencia del medicamento baricitinib fabricado por el laboratorio Eli Lilly and Co, en combinaci\u00f3n con el remdesivir de Gilead Sciences Inc, para el tratamiento de pacientes con COVID-19, seg\u00fan inform\u00f3 la agencia AP.<\/p>\n\n\n\n<p>En efecto, el f\u00e1rmaco baricitinib para la artritis reumatoide puede bloquear la entrada viral y reducir la mortalidad en pacientes con COVID-19 cuyo estado va de moderado a grave, basado en una revisi\u00f3n de los datos de un ensayo cl\u00ednico de pacientes hospitalizados patrocinado por el Instituto Nacional de Alergias y Enfermedades Infecciosas.<\/p>\n\n\n\n<p>El ensayo, que involucr\u00f3 a 1.000 pacientes asignados aleatoriamente, mostr\u00f3 una reducci\u00f3n de aproximadamente un d\u00eda en el promedio del tiempo de recuperaci\u00f3n para los pacientes tratados con la combinaci\u00f3n frente a los tratados s\u00f3lo con remdesivir.<\/p>\n\n\n\n<p>El baricitinib, que se vende con la marca Olumiant, es un medicamento oral aprobado por la FDA para tratar la artritis reumatoide activa de moderada a grave. Se trata de una forma inusual de la artritis que ocurre cuando el sistema inmunol\u00f3gico ataca las articulaciones, causando inflamaci\u00f3n.<\/p>\n\n\n\n<p>INFOBAE<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Las autoridades sanitarias de Estados Unidos aprobaron este jueves el uso de emergencia del medicamento baricitinib fabricado por el laboratorio Eli Lilly and Co, en combinaci\u00f3n con el remdesivir de Gilead Sciences Inc, para el tratamiento de pacientes con COVID-19, seg\u00fan inform\u00f3 la agencia AP. En efecto, el f\u00e1rmaco baricitinib para la artritis reumatoide puede [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":780,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[67],"tags":[],"class_list":["post-779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/minutocerord.com\/?p=779\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD\" \/>\n<meta property=\"og:description\" content=\"Las autoridades sanitarias de Estados Unidos aprobaron este jueves el uso de emergencia del medicamento baricitinib fabricado por el laboratorio Eli Lilly and Co, en combinaci\u00f3n con el remdesivir de Gilead Sciences Inc, para el tratamiento de pacientes con COVID-19, seg\u00fan inform\u00f3 la agencia AP. En efecto, el f\u00e1rmaco baricitinib para la artritis reumatoide puede [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/minutocerord.com\/?p=779\" \/>\n<meta property=\"og:site_name\" content=\"Minuto Cero RD\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Genofnotes\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/Genofnotes\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-20T03:43:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-20T03:43:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437\" \/>\n\t<meta property=\"og:image:width\" content=\"822\" \/>\n\t<meta property=\"og:image:height\" content=\"437\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genof\u00f3ntes Urb\u00e1ez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genof\u00f3ntes Urb\u00e1ez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779\"},\"author\":{\"name\":\"Genof\u00f3ntes Urb\u00e1ez\",\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#\\\/schema\\\/person\\\/60b5372d60aaa0a5171fb6488be9aee6\"},\"headline\":\"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19\",\"datePublished\":\"2020-11-20T03:43:47+00:00\",\"dateModified\":\"2020-11-20T03:43:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779\"},\"wordCount\":209,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#\\\/schema\\\/person\\\/60b5372d60aaa0a5171fb6488be9aee6\"},\"image\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/minutocerord.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Baricitinib.jpg?fit=822%2C437&ssl=1\",\"articleSection\":[\"Salud\"],\"inLanguage\":\"es-DO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"http:\\\/\\\/minutocerord.com\\\/?p=779#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779\",\"url\":\"http:\\\/\\\/minutocerord.com\\\/?p=779\",\"name\":\"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#primaryimage\"},\"image\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/minutocerord.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Baricitinib.jpg?fit=822%2C437&ssl=1\",\"datePublished\":\"2020-11-20T03:43:47+00:00\",\"dateModified\":\"2020-11-20T03:43:50+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#breadcrumb\"},\"inLanguage\":\"es-DO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/minutocerord.com\\\/?p=779\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-DO\",\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/minutocerord.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Baricitinib.jpg?fit=822%2C437&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/minutocerord.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/Baricitinib.jpg?fit=822%2C437&ssl=1\",\"width\":822,\"height\":437},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/minutocerord.com\\\/?p=779#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/minutocerord.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#website\",\"url\":\"https:\\\/\\\/minutocerord.com\\\/\",\"name\":\"Minuto Cero RD\",\"description\":\"Periodismo serio y veraz\",\"publisher\":{\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#\\\/schema\\\/person\\\/60b5372d60aaa0a5171fb6488be9aee6\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/minutocerord.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-DO\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/minutocerord.com\\\/#\\\/schema\\\/person\\\/60b5372d60aaa0a5171fb6488be9aee6\",\"name\":\"Genof\u00f3ntes Urb\u00e1ez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-DO\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g\",\"caption\":\"Genof\u00f3ntes Urb\u00e1ez\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g\"},\"description\":\"Periodista \\\/ Locutor\",\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Genofnotes\",\"https:\\\/\\\/www.instagram.com\\\/genofnotes\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/minutocerord.com\/?p=779","og_locale":"es_ES","og_type":"article","og_title":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD","og_description":"Las autoridades sanitarias de Estados Unidos aprobaron este jueves el uso de emergencia del medicamento baricitinib fabricado por el laboratorio Eli Lilly and Co, en combinaci\u00f3n con el remdesivir de Gilead Sciences Inc, para el tratamiento de pacientes con COVID-19, seg\u00fan inform\u00f3 la agencia AP. En efecto, el f\u00e1rmaco baricitinib para la artritis reumatoide puede [&hellip;]","og_url":"http:\/\/minutocerord.com\/?p=779","og_site_name":"Minuto Cero RD","article_publisher":"https:\/\/www.facebook.com\/Genofnotes","article_author":"https:\/\/www.facebook.com\/Genofnotes","article_published_time":"2020-11-20T03:43:47+00:00","article_modified_time":"2020-11-20T03:43:50+00:00","og_image":[{"width":822,"height":437,"url":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437","type":"image\/jpeg"}],"author":"Genof\u00f3ntes Urb\u00e1ez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Genof\u00f3ntes Urb\u00e1ez","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/minutocerord.com\/?p=779#article","isPartOf":{"@id":"http:\/\/minutocerord.com\/?p=779"},"author":{"name":"Genof\u00f3ntes Urb\u00e1ez","@id":"https:\/\/minutocerord.com\/#\/schema\/person\/60b5372d60aaa0a5171fb6488be9aee6"},"headline":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19","datePublished":"2020-11-20T03:43:47+00:00","dateModified":"2020-11-20T03:43:50+00:00","mainEntityOfPage":{"@id":"http:\/\/minutocerord.com\/?p=779"},"wordCount":209,"commentCount":0,"publisher":{"@id":"https:\/\/minutocerord.com\/#\/schema\/person\/60b5372d60aaa0a5171fb6488be9aee6"},"image":{"@id":"http:\/\/minutocerord.com\/?p=779#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437&ssl=1","articleSection":["Salud"],"inLanguage":"es-DO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["http:\/\/minutocerord.com\/?p=779#respond"]}]},{"@type":"WebPage","@id":"http:\/\/minutocerord.com\/?p=779","url":"http:\/\/minutocerord.com\/?p=779","name":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19 - Minuto Cero RD","isPartOf":{"@id":"https:\/\/minutocerord.com\/#website"},"primaryImageOfPage":{"@id":"http:\/\/minutocerord.com\/?p=779#primaryimage"},"image":{"@id":"http:\/\/minutocerord.com\/?p=779#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437&ssl=1","datePublished":"2020-11-20T03:43:47+00:00","dateModified":"2020-11-20T03:43:50+00:00","breadcrumb":{"@id":"http:\/\/minutocerord.com\/?p=779#breadcrumb"},"inLanguage":"es-DO","potentialAction":[{"@type":"ReadAction","target":["http:\/\/minutocerord.com\/?p=779"]}]},{"@type":"ImageObject","inLanguage":"es-DO","@id":"http:\/\/minutocerord.com\/?p=779#primaryimage","url":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437&ssl=1","contentUrl":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437&ssl=1","width":822,"height":437},{"@type":"BreadcrumbList","@id":"http:\/\/minutocerord.com\/?p=779#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/minutocerord.com\/"},{"@type":"ListItem","position":2,"name":"Estados Unidos aprob\u00f3 el uso de emergencia del medicamento baricitinib para tratamientos contra el COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/minutocerord.com\/#website","url":"https:\/\/minutocerord.com\/","name":"Minuto Cero RD","description":"Periodismo serio y veraz","publisher":{"@id":"https:\/\/minutocerord.com\/#\/schema\/person\/60b5372d60aaa0a5171fb6488be9aee6"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/minutocerord.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-DO"},{"@type":["Person","Organization"],"@id":"https:\/\/minutocerord.com\/#\/schema\/person\/60b5372d60aaa0a5171fb6488be9aee6","name":"Genof\u00f3ntes Urb\u00e1ez","image":{"@type":"ImageObject","inLanguage":"es-DO","@id":"https:\/\/secure.gravatar.com\/avatar\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g","caption":"Genof\u00f3ntes Urb\u00e1ez"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/a49ef3186a692098ac3e8a1612261e3ad70cf9e44553dff2929e67939a0ecb9d?s=96&d=identicon&r=g"},"description":"Periodista \/ Locutor","sameAs":["https:\/\/www.facebook.com\/Genofnotes","https:\/\/www.instagram.com\/genofnotes\/"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/minutocerord.com\/wp-content\/uploads\/2020\/11\/Baricitinib.jpg?fit=822%2C437&ssl=1","jetpack-related-posts":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/posts\/779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/minutocerord.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=779"}],"version-history":[{"count":1,"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/posts\/779\/revisions"}],"predecessor-version":[{"id":781,"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/posts\/779\/revisions\/781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/minutocerord.com\/index.php?rest_route=\/wp\/v2\/media\/780"}],"wp:attachment":[{"href":"https:\/\/minutocerord.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/minutocerord.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/minutocerord.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}